BioHarvest Sciences reported a quarterly loss of $0.11 per share, beating the Zacks Consensus Estimate of a $0.13 loss by $0.02 per share. The loss also narrowed versus a $0.13 per share loss a year ago, indicating modest improvement in profitability. The print is positive relative to expectations, but the overall market impact is likely limited.
BioHarvest Sciences reported a quarterly loss of $0.11 per share, beating the Zacks Consensus Estimate of a $0.13 loss by $0.02 per share. The loss also narrowed versus a $0.13 per share loss a year ago, indicating modest improvement in profitability. The print is positive relative to expectations, but the overall market impact is likely limited.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
